Leukemia  >>  Duvyzat (givinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duvyzat (givinostat) / Italfarmaco
NCT00792831 / 2006-005465-19: Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia

Terminated
2
3
Europe
ITF2357, Givinostat
Italfarmaco
Chronic Lymphocytic Leukemia
04/09
04/09
2005-005321-63: Multicentre, open label, uncontrolled, pilot, phase II study of oral ITF2357 in subjects with acute myeloid leukemia refractory/resistant and/or not suitable for any alternative therapy

 
2
31
Europe
ITF2357,
ITALFARMACO
Acute myeloid leukemia AML (any French-American-British [FAB] type with the exception of M3 subtype, acute promyelocytic leukemia
 
 

Download Options